07
October
2016
|
09:00 AM
Europe/Amsterdam

Isagenix Study Published in Peer-Reviewed Journals

Isagenix International, a global health and wellness company, was recently the topic of a scientific study published in two peer-reviewed journals, Nutrients and Frontiers in Physiology.

The studies were conducted by researchers at Skidmore College in New York under the direction of principal investigator Paul J. Arciero, Ph.D., and designed to see if Isagenix products aided in effective weight loss and long-term weight maintenance. The study was broken into two phases: Phase One lasting 12 weeks and Phase Two lasting 52 weeks.

Results showed study participants on average lost a total of one third their visceral fat (located around one’s midsection), gained lean mass, had better arterial health, and enhanced metabolism after using Isagenix products.

“As an active nutrition and exercise science researcher for over 30 years, these were very impressive findings and clearly established our protein-pacing [Shake Days] and intermittent fasting diet regimen [Cleanse Days] as an effective short- and long-term strategy to promote healthy body weight, abdominal and visceral fat mass loss as well as enhanced metabolism and cardiovascular health compared to other commonly prescribed diets,” Dr. Arciero said.

The success of this study was in conjunction with the Isagenix 30-Day System. For the last 14 years, Isagenix has been developing cutting-edge products that help target five key areas: weight loss, healthy aging, energy, performance, and wealth creation. To date, the health and wellness company has helped thousands find a solution for shredding unwanted pounds, boosting energy, improving endurance, and creating residual income.

This is the fourth time Isagenix had a study published in a peer-review journal and shows the company’s continued commitment to scientific research on its products.

Earlier studies appeared in Nutrition Journal and in Nutrition and Metabolism in 2012.

The new Skidmore College study was registered at National Institute of Health’s ClinicalTrials.gov, a publicly and privately supported registry of clinical studies conducted around the world.

About Isagenix International

Established in 2002, Isagenix International believes that everyone deserves to experience a healthy, joyful, and abundant life. The global wellbeing company artfully crafts more than 175 effective products and offers a supportive community for its more than 550,000 customers worldwide. Isagenix shares its products through a network of independent distributors in 26 markets: the United States, Canada, Puerto Rico, Hong Kong, Australia, New Zealand, Taiwan, Mexico, the United Kingdom, Ireland, the Netherlands, Belgium, Spain, South Korea, Austria, Denmark, Finland, France, Germany, Italy, Japan, Norway, Poland, Portugal, Sweden, and Switzerland. The private family-owned company has its world headquarters in Gilbert, Arizona. For more information, visit Isagenix.com​.